Saturday December 14, 2019
|
Subscribe
|
Contribute
|
About
|
Access Your Account
|
Register
|
Login
|
Home
|
Current Issue
|
Issue Archive
|
Featured Reports
|
eBooks
|
BioProcess Insider
|
Multimedia
|
BPI White Papers
|
Webinars
|
Posters
|
BioProcess International Events
|
BioProcess International Asia 2020
|
BioProcess International US West
|
BioProcess International Academy
|
Events
Covering the whole development process for the global biotechnology industry
Upstream
Processing
Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
Assays
Biochemicals/Raw Materials
Bioreactors
Cell Culture Media
Expression Platforms
Fermentation
Perfusion Cell Culture
Upstream Contract Services
Upstream Single-Use Technologies
Downstream
Processing
Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
Filtration
Separation/Purification
Viral Clearance
Chromatography
Downstream Contract Services
Downstream Single-Use Technologies
Manufacturing
Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
Personalized Medicine
Single Use
Supply Chain
Vaccines
MAb
Biosimilars
Cell Therapies
Emerging Therapeutics
Facility Design/Engineering
Continuous Bioprocessing
Fill/Finish
Formulation
Information Technology
Manufacturing Contract Services
Process Monitoring and Controls
Analytical
Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
Culture Development
Cell Line Development
Downstream Development
Downstream Validation
Laboratory Equipment
PAT
Pre-Formulation
Product Characterization
QA/QC
Upstream Development
Upstream Validation
Leachables/Extractables/Particulates
Business
Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
Careers
CMC Forums
Economics
Intellectual Property
Pre-Clinical and Clinical Trials
Regulatory Affairs
Risk Management
BioRegions
Expression Platforms
Mammalian Expression of Therapeutic Proteins
by
BPI Contributor
Enhancing Therapeutic Antibodies and Titer Yields of Mammalian Cell Lines
by
BPI Contributor
Microbial Systems for the Manufacture of Therapeutic Antibody Fragments
by
BPI Contributor
Chapter 2: Animal Cell Culture
by
BPI Contributor
Acknowledgments: More Production Options Than Ever Before
by
BPI Contributor
Glossary: The Language of Expressions Technology
by
BPI Contributor
Microbial Process Development for BioPharmaceuticals
by
BPI Contributor
Chapter 6: A Multitude of Fears
by
BPI Contributor
Chapter 5: Transgenic Plants
by
BPI Contributor
Chapter 4: Transgenic Animals
by
BPI Contributor
<
1
...
2
3
4
5
6
7
8
9
10
11
>
Home
Current Issue
Issue Archive
▼
Featured Reports
eBooks
BioProcess Insider
Multimedia
▼
BPI White Papers
Webinars
Posters
BioProcess International Events
▼
BioProcess International Asia 2020
BioProcess International US West
BioProcess International Academy
Events
